150 related articles for article (PubMed ID: 8637439)
1. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father.
Cobb MM; Salen G; Tint GS; Greenspan J; Nguyen LB
Metabolism; 1996 Jun; 45(6):673-9. PubMed ID: 8637439
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
Nguyen LB; Cobb M; Shefer S; Salen G; Ness GC; Tint GS
J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject.
Cobb MM; Salen G; Tint GS
J Am Coll Nutr; 1997 Dec; 16(6):605-13. PubMed ID: 9430090
[TBL] [Abstract][Full Text] [Related]
4. A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia.
Parsons HG; Jamal R; Baylis B; Dias VC; Roncari D
Clin Invest Med; 1995 Oct; 18(5):389-400. PubMed ID: 8529322
[TBL] [Abstract][Full Text] [Related]
5. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis. Comparison with lovastatin.
Nguyen L; Salen G; Shefer S; Shore V; Tint GS; Ness G
Arteriosclerosis; 1990; 10(2):289-97. PubMed ID: 2317163
[TBL] [Abstract][Full Text] [Related]
6. Tuberous xanthomas in sitosterolemia.
Alam M; Garzon MC; Salen G; Starc TJ
Pediatr Dermatol; 2000; 17(6):447-9. PubMed ID: 11123775
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.
Yokoyama S; McCoy E
J Inherit Metab Dis; 1992; 15(2):291-2. PubMed ID: 1528002
[No Abstract] [Full Text] [Related]
8. Response to diet and cholestyramine in a patient with sitosterolemia.
Belamarich PF; Deckelbaum RJ; Starc TJ; Dobrin BE; Tint GS; Salen G
Pediatrics; 1990 Dec; 86(6):977-81. PubMed ID: 2251034
[TBL] [Abstract][Full Text] [Related]
9. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
[TBL] [Abstract][Full Text] [Related]
11. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects.
Salen G; Xu G; Tint GS; Batta AK; Shefer S
J Lipid Res; 2000 Nov; 41(11):1883-9. PubMed ID: 11060358
[TBL] [Abstract][Full Text] [Related]
12. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis.
Salen G; Starc T; Sisk CM; Patel SB
Gastroenterology; 2006 May; 130(6):1853-7. PubMed ID: 16697747
[TBL] [Abstract][Full Text] [Related]
13. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and bile acid synthesis in two families with homozygous and heterozygous hypercholesterolemia.
Miettinen TA
Arteriosclerosis; 1984; 4(4):383-8. PubMed ID: 6466195
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia.
Nguyen LB; Shefer S; Salen G; Tint SG; Batta AK
Proc Assoc Am Physicians; 1998; 110(1):32-9. PubMed ID: 9460081
[TBL] [Abstract][Full Text] [Related]
16. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
17. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
18. [Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy].
Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; García Alegría JJ; Gascón Luna F; Masana Marín L
An Esp Pediatr; 1990 Jul; 33(1):58-60. PubMed ID: 2252289
[TBL] [Abstract][Full Text] [Related]
19. Sitosterolemia.
Salen G; Patel S; Batta AK
Cardiovasc Drug Rev; 2002; 20(4):255-70. PubMed ID: 12481199
[TBL] [Abstract][Full Text] [Related]
20. Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism.
Tsubakio-Yamamoto K; Nishida M; Nakagawa-Toyama Y; Masuda D; Ohama T; Yamashita S
J Atheroscler Thromb; 2010 Sep; 17(9):891-900. PubMed ID: 20543520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
